A presentation which details the importance of why you should prescribe and discharge LMWH by brand name. Enoxaparin now has an originator biologic and three biosimilars and hospitals will choose a main LMWH to use. Patients are then trained to self-inject on a specific brand. This session will detail why LMWH should be brand discharged and the effect of this.